Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes

J Cell Physiol. 2019 Nov;234(11):19785-19798. doi: 10.1002/jcp.28578. Epub 2019 Apr 1.

Abstract

Morin (MO), a natural bioflavinoid, exists in many herbs. Previous studies have acclaimed MO's anti-inflammatory, antidiabetic, antioxidant, antifibrotic, anticancer, and antihyperglycemic biological effects. This study aimed to assess the molecular mechanism of MO involved in the oleic acid (OA)-induced inflammatory damage and lipid accumulation in HepG2 cell and tyloxapol (Ty)-induced hyperlipidemia in mice. We found that MO can efficaciously mitigate reactive tumor necrosis factor-α (TNF-α) level and triglyceride (TG) accumulation in OA-induced HepG2 cell and in tyloxapol-induced mice. Next, the study testified that MO apparently suppressed OA-excited nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs) signaling pathways in HepG2 cell. In addition, MO distinctly upregulated the expression of peroxisome proliferator-activated receptor α (PPARα) and decreased the expression of sterol regulatory element-binding protein 1c (SREBP-1c) in OA-induced HepG2 cell and in tyloxapol-induced mice, both of which are dependent upon the phosphorylation of acetyl-CoA carboxylase (ACC), adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK), and protein kinase B (AKT). In conclusion, these results suggest that MO has protective potential against hyperlipidemia and steatosis, and the potential mechanism may have a close relation with activation of PPARα and inhibition of SREBP-1c.

Keywords: PPARα; SREBP-1c; lipid metabolism; morin; steatosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Acetyl-CoA Carboxylase / genetics
  • Animals
  • Flavonoids / pharmacology*
  • Hep G2 Cells
  • Hepatocytes / drug effects
  • Hepatocytes / pathology
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / genetics
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Inflammation / genetics
  • Lipid Metabolism / drug effects
  • Mice
  • Non-alcoholic Fatty Liver Disease / chemically induced
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / genetics
  • Oleic Acid / toxicity
  • PPAR alpha / genetics
  • Phosphorylation / drug effects
  • Polyethylene Glycols / toxicity
  • Protein Kinases / genetics
  • Proto-Oncogene Proteins c-akt / genetics
  • Signal Transduction / drug effects
  • Sterol Regulatory Element Binding Protein 1 / genetics
  • Triglycerides / metabolism

Substances

  • Flavonoids
  • PPAR alpha
  • PPARA protein, human
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • Oleic Acid
  • Polyethylene Glycols
  • morin
  • Protein Kinases
  • Proto-Oncogene Proteins c-akt
  • AMP-Activated Protein Kinase Kinases
  • Acetyl-CoA Carboxylase
  • tyloxapol